News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vitrolife: Allotment of Acquisition Cost Decided by the Swedish Tax Agency


12/20/2012 9:31:11 AM

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News:

In connection with Vitrolife’s (STO:VITR) distribution of the shares in Xvivo Perfusion AB, the Swedish Tax Agency has decided that 77% of the acquisition cost should be allotted to Vitrolife AB and 23% to Xvivo Perfusion AB.

Read at BioSpace.com

comments powered by Disqus
Vitrolife
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES